VISN padiopharmaceutical pluvicto drug
Active Awarded Last action
- Contract number
- 36C24925A0031
- Awardee
-
Advanced Accelerator Applications USA Inc. UEI JNM4NBNHFE66
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 2 $888,455 obligated
Award facts
- Opportunity
-
- 6505--Intent to Sole Source VISN Wide Radiopharmaceutical Pluvicto Blanket purchase agreement (BPA) Special Notice · 36C24924Q0314 · Posted Jun 12, 2024
- Combined order value
- $5,075,551 Current and potential, with all options
- Last date to order 37% complete
- IDV ceiling 2% used
- $49,141,097.46
- Maximum order
- $10,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Advanced Accelerator Applications USA Inc., a Novartis subsidiary specializing in radiopharmaceutical manufacturing, was awarded a single-award Blanket Purchase Agreement valued at $49.1 million by Veterans Integrated Service Network 9 (VISN 9) on December 20, 2024, with ultimate completion on December 19, 2029. The BPA, established under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), procures PLUVICTO (lutetium Lu 177 vipivotide tetraxetan), an advanced radiopharmaceutical therapeutic agent indicated for targeted radioligand therapy in cancer treatment, primarily prostate cancer. The contract contains no small business set-aside designation, reflecting the contractor's status as a large specialized manufacturer. Performance locations include the contractor's facilities in Millburn and East Hanover, New Jersey, with distribution to Veterans Affairs medical centers throughout VISN 9's service area in Tennessee and Kentucky. The Department of Veterans Affairs issued this sole-source procurement through a Special Notice published June 12, 2024, with a response deadline of June 27, 2024, inviting capability statements from interested parties prior to award.
Two delivery orders have been issued against this BPA master contract vehicle. The first delivery order, awarded December 20, 2025, totals $2.37 million for PLUVICTO supply with completion targeted for December 19, 2029, with performance at the East Hanover, New Jersey facility. A second BPA call, awarded December 20, 2024, valued at $498,437.10 on a firm fixed-price basis for PLUVICTO drug delivery, maintains a completion date of December 19, 2025, with performance at the Millburn, New Jersey location. Both delivery orders utilize firm fixed-price contract terms and support the VA's provision of specialized nuclear medicine therapeutic capabilities to veteran beneficiaries. These contract vehicles enable VISN 9 to issue task orders and delivery orders on an as-needed basis, facilitating flexible and efficient procurement of this specialized radiopharmaceutical to support cancer diagnostic and therapeutic capabilities across Veterans Affairs healthcare facilities.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| VISN padiopharmaceutical pluvicto drug | Veterans Integrated Service Network 9 (VHA) | $888,455 | |
| VISN padiopharmaceutical pluvicto drug | Veterans Integrated Service Network 9 (VHA) | $0 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36C24925A0031?
36C24925A0031 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 9 (Veterans Health Administration) on December 20, 2024.
How much is contract 36C24925A0031 worth?
Orders under 36C24925A0031 have obligated $888,455. Their combined current value, with exercised options, is $5,075,551. 36C24925A0031's own ceiling is $49,141,097. A single order can be worth up to $10,000,000.
How many orders have been placed under contract 36C24925A0031?
2 orders have been placed under 36C24925A0031, the latest on December 20, 2025.
Who can order from contract 36C24925A0031?
36C24925A0031 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36C24925A0031 under another contract?
Yes. 36C24925A0031 is a blanket purchase agreement under 36F79719D0169, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24925A0031 competed?
The extent of competition for 36C24925A0031 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV